A Physician-Based Trial to Increase Colorectal Cancer Screening in Chinese
50 Years
74 Years
Both
Colorectal Cancer
Trial Information
A Physician-Based Trial to Increase Colorectal Cancer Screening in Chinese
This study is a randomized controlled trial aiming to test the effect of the
culturally-tailored in-office based intervention on physicians. A total of 24 Chinese
physicians in the Washington DC and Philadelphia areas and a total of 24 eligible Chinese
patients from each physician will be recruited for this study. Physicians and their patients
are randomized into two groups: A and B. Physician in the intervention group (A) will
receive mailed printed materials including a CRC physician guide, patient brochure, flip
chart and a poster and two sessions of in-office training aimed to reinforce learning of the
topic covered by the mailed materials and provide physicians with hands-on experience in
using communication skills with standardized patients. Physicians in the control group (B)
will receive nothing until the end of the study. Patients will be followed 12-month later
after their completion of the baseline survey and their self-reported CRC screening status
will be verified by chart audit.
Inclusion Criteria:
For Physicians
1. are Chinese American,
2. practice primary care,
3. have a least 75 Chinese patients aged 50 and older in their practice,
4. can communicate with patients in Chinese (Mandarin, Cantonese, etc.)
For Patients
1. visiting the participating physician at least once in the past 2 years,
2. are Chinese Americans,
3. are 50 years and older,
4. never had any CRC screening or are overdue for screening.
Exclusion Criteria:
For Patients:
1. have a colorectal polyp, CRC cancer, or a family history of CRC (first degree
relative), and
2. had updated CRC screening (FOBT within one year, colonoscopy within 10 years,
sigmoidoscopy within 5 years and double-contrast barium enema within 5 years).
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Outcome Measure:
Receipt of CRC screening
Outcome Description:
Nonadherent Chinese American patient's CRC screening rates.
Outcome Time Frame:
12 months
Safety Issue:
No
Principal Investigator
Judy Wang, Ph.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
Georgetown University
Authority:
United States: Federal Government
Study ID:
2007-297
NCT ID:
NCT01289288
Start Date:
July 2007
Completion Date:
July 2012
Related Keywords:
- Colorectal Cancer
- colorectal cancer screening
- Chinese Americans
- patients nonadherent with CRC Screening
- Colorectal Neoplasms
Name | Location |
|---|---|
| Temple University | Philadelphia, Pennsylvania 19140 |
| Georgetown University | Washington, District of Columbia 20007-2197 |
